![The Radcliffe Cardiology Podcast](https://assets.radcliffecardiology.com/s3fs-public/podcast/2024-01/DELV-4317_IND_RadcliffePodcast_Brand_1080x1080%20%281%29.png?VersionId=0_xtiGz.9E0.ktP3ZIVRPtq5FM11oxcn)
The Radcliffe Cardiology Podcast
The Radcliffe Cardiology Podcast brings you the latest advancements, research and best practices in the field of cardiology. Each episode features expert insights and engaging discussions with leading healthcare professionals, covering a breadth of topics in cardiovascular science.
Our podcast aims to build on the best science, with key takeaways from the top cardiology conferences and recent publications from our journals.
Read MoreRead Less
All Episodes
![Ep 3: Atrial Fibrillation in Congenital Heart Disease](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-4320_ECR_EP_3_1920x1080%20v3.png?VersionId=kPZk7Lew6LRRdV6UCMcHFsWwMrL9V8dw&itok=cDFXAsHI)
Did you know that atrial arrhythmias are the most common complication in adults with congenital heart disease?
Dr Irene Martin de Miguel (Hospital General Universitario Gregorio Marañón, Madrid, Spain) joins us in this featured author episode to outline her recent review article, Atrial Fibrillation in Congenital Heart Disease. In this podcast, Dr de Miguel provides an overview of the current knowledge of AF in CHD, giving practical recommendations for your everyday practice.
Read More
Dr Irene Martin de Miguel (Hospital General Universitario Gregorio Marañón, Madrid, Spain) joins us in this featured author episode to outline her recent review article, Atrial Fibrillation in Congenital Heart Disease. In this podcast, Dr de Miguel provides an overview of the current knowledge of AF in CHD, giving practical recommendations for your everyday practice.
![Ep 2: Prognostication of patients with coronary stenoses: pre-and post-PCI](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-4319_ECR_EP_2_1920x1080%20v3.png?VersionId=bukoHVbSemq1t83.c_D3Usxnt8KwPkoo&itok=rSSi6KIJ)
Is there enough evidence to support the prognostic value of coronary physiology measurements in pre-and post-PCI settings? Is post-PCI FFR ready for clinical practice?
Today's episode features co-hosts Dr Peter Ong and Dr Andreas Seitz (Robert-Bosch Hospital, Stuttgart, DE) who together summarise the main results from the TARGET FFR and DEFINE-FLOW trials that were presented at TCT Connect 2020 and published recently in ECR journal, in the context of the existing literature.
Read More
Today's episode features co-hosts Dr Peter Ong and Dr Andreas Seitz (Robert-Bosch Hospital, Stuttgart, DE) who together summarise the main results from the TARGET FFR and DEFINE-FLOW trials that were presented at TCT Connect 2020 and published recently in ECR journal, in the context of the existing literature.
![Ep 1: Women and Heart Disease](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-4318_ECR_EP_1_1920x1080%20v3.png?VersionId=g7z8yRhLIJQXcXKyC2nImfIWHuJEly7L&itok=uZmwNYgJ)
Did you know that CV disease is the leading cause of death in women and that women are more likely to die of heart disease compared to men? Dr Erin Michos (John Hopkins Uni, US) and Dr Martha Gulati (Uni of Arizona, US) join us on the inaugural episode of the ECR podcast series to discuss issues surrounding women in heart disease. Together they explore a variety of topics that are addressed in the latest special focus issue in the European cardiology Review journal.
Read More
![Ep 9: Sex Differences in Hypertension: Pharmacological Treatment](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9601_ECR_EP_9_1920x1080%20v3.png?VersionId=nCxO.HFAMlDaoa97AIyluRc.84J.YW8d&itok=vDNVphfl)
In the first of a three-part ECR Podcast series on hypertension in women, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Prof Juan Tamargo (University Complutense, Madrid, ES) to discuss pharmalogical treatment options and considerations.
Read More
![Ep 8: The Role of CT Coronary Angiography in Chronic Total Occlusion Intervention](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9963_ECR_EP_8_1920x1080%20v3.png?VersionId=H_PpHdkBlsXWwIM3CU7OKBWfwKsIMhOC&itok=O0IMbo0q)
What considerations must be made when screening chronic total occlusion patients undergoing PCI, and how can CT be used in daily practice?
In this month's episode of ECR Podcast, Dr Vinoda Sharma, (Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK) and Dr Abdul Mozid, (Leeds Teaching Hospitals NHS Trust, Leeds, UK) discuss the ways in which CT coronary angiography can be utilised in chronic total occlusion percutaneous coronary interventions, and how the procedures differ across their UK-based practices.
Read More
In this month's episode of ECR Podcast, Dr Vinoda Sharma, (Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK) and Dr Abdul Mozid, (Leeds Teaching Hospitals NHS Trust, Leeds, UK) discuss the ways in which CT coronary angiography can be utilised in chronic total occlusion percutaneous coronary interventions, and how the procedures differ across their UK-based practices.
![Ep 7: Socioeconomic Factors Impacting Coronary and Structural Intervention](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9732_ECR_EP_7_1920x1080%20v3.png?VersionId=fgC9qTTpBbEunJ3lA84.aIkG9IzVbjOr&itok=CFcrw78V)
What are the social factors that impact access to coronary and structural intervention in the current landscape of cardiology? In this month's episode of ECR Podcast, guest editor of ECR's special focus on gender disparities in interventional and structural heart procedures, Dr Natalia Berry (Mid Atlantic Permanente Medical Group, Washington DC, USA) is joined by Dr Renee Bullock-Palmer, (Deborah Heart and Lung Center, Pemberton, NJ, USA) to answer some of these questions.
Read More
![Ep 6: Inflammatory Biomarkers and Cardiovascular Risk](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9377_ECR_EP_6_1920x1080%20v3.png?VersionId=2TBpob7jjjEZqtHM9MlG6vf3aq2uUdnt&itok=zCk6OoPd)
What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event?
Read More
![Targeting Inflammation in Atherosclerosis: Current Guidelines and Clinical Data](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6314_NN_Kaski_Fiolet_1920x1080.png?VersionId=zzBXlqg17rbiXsBjYW5OHA7u7mXUg3qd&itok=8f3Ze18J)
Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) as they explore topics such as how guidelines currently view anti-inflammatory approaches and main molecules under investigation.
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More
Supported by an unrestricted educational grant from NOVO NORDISK A/S.